Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia

Mikkel Krogh-Madsen

Status: Completed

Conditions: Acute Myeloid Leukemia

Treatments: Other: PK-PD analysis

Study type: Observational

Funder types: Other

Identifiers

NCT00969891

AMLPKPD-20081127

EudraCT nummer 2008-008165-35

Details and patient eligibility

About

The present study is not hypothesis driven but will explore the ability of pharmacokinetic-pharmacodynamic modelling to predict optimal dosage of the chemotherapeutic drugs used in therapy in adult patients with acute myeloid leukemia.

Enrollment: 23 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• adult men and women with newly diagnosed acute myeloid leukemia

Exclusion criteria

• under age 18 years

Trial design

23 participants in 1 patient group

AML patients in induction treatment

Treatment:

Other: PK-PD analysis